HOOKIPA Pharma Inc (HOOK)
0.7976
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
0.8499
+0.05
(+6.56%)
Pre-Market: 08:03
HOOKIPA Pharma Revenue (TTM): 20.13M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 20.13M |
September 30, 2023 | 20.55M |
June 30, 2023 | 15.91M |
March 31, 2023 | 15.98M |
December 31, 2022 | 14.25M |
September 30, 2022 | 10.32M |
June 30, 2022 | 11.96M |
March 31, 2022 | 14.59M |
December 31, 2021 | 18.45M |
September 30, 2021 | 19.72M |
Date | Value |
---|---|
June 30, 2021 | 19.88M |
March 31, 2021 | 21.19M |
December 31, 2020 | 19.58M |
September 30, 2020 | 18.04M |
June 30, 2020 | 16.04M |
March 31, 2020 | 13.40M |
December 31, 2019 | 11.94M |
September 30, 2019 | 13.40M |
June 30, 2019 | 13.27M |
March 31, 2019 | 9.864M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.32M
Minimum
Sep 2022
21.19M
Maximum
Mar 2021
16.24M
Average
15.98M
Median
Mar 2023
Revenue (TTM) Benchmarks
Absci Corp | 5.718M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |